DCN and familial pancreatic carcinoma: Few studies have investigated DCN expression in PDAC, but Köninger et al found that DCN is upregulated in tumour stroma compared to normal tissue and that DCN exerts dual actions, both inhibiting tumour growth and attenuating the effect of carboplatin and gemcitabine on pancreatic cancer cells in vitro [36].